Last week, my colleagues Erin, Margaret and I (that’s us in the lab coats) went on a tour of the Aeras Global TB Vaccine facility in Rockville, Maryland. We were there to learn more about the need for a new tuberculosis (TB) vaccine and to see how the vaccine development process works.
If you remember back in March, when we met with global leaders in The Hague, the Global Fund released some impressive reports detailing their work to combat HIV/AIDS, tuberculosis, and malaria. Now, just a few months later, they’ve released new data, and the results are astounding:
The WHO just released its 2010 report on multidrug and extensively drug-resistant tuberculosis (M/XDR-TB) surveillance and response, providing the latest information on the status of this global epidemic.
This website is financed in part with financial assistance from the European Union. The contents though are the sole responsibility of GCAP and can under no circumstances be regarded as reflecting the position of the European Union.